Officials with Vanderbilt University Medical Center (VUMC) announce the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.
Through Nashville Biosciences, pharmaceutical and other life science companies can leverage the wealth of data contained within the Medical Center’s genomics and health information technology resources to accelerate their discovery and development of new treatments for patients, while helping to support institutional research efforts.
“Partnering with the pharmaceutical and broader life sciences industry through Nashville Biosciences will enable VUMC to expand and support its mission of advancing translational and precision medicine,” said Leeland Ekstrom, PhD, Chief Operating Officer of Nashville Biosciences.
Nashville Biosciences will serve as a commercial interface between outside companies and the formidable research resources housed in VUMC, including its comprehensive databank BioVU which contains more than 250,000 DNA samples collected over the last decade, coupled with 2.8 million de-identified patient records.
Read the complete article here.